Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7577
Peer-review started: February 18, 2022
First decision: March 24, 2022
Revised: April 5, 2022
Accepted: May 28, 2022
Article in press: May 28, 2022
Published online: July 26, 2022
Processing time: 143 Days and 6.7 Hours
Effusive-constrictive pericarditis (ECP) is an uncommon pericardial syndrome. Careful echocardiographic examination may provide helpful information not only for diagnosing but also for managing ECP. ECP has various etiologies; however, Pseudomonas aeruginosa (P. aeruginosa) infection has not been reported as a cause to date. Herein, we present a rare case of ECP caused by P. aeruginosa infection, which was followed up using echocardiography.
A 30-year-old man was admitted to our hospital with a 2-mo history of cough, dyspnea, bloating, palpitations, and lower-extremity edema. The patient was initially diagnosed with pericardial effusion by transthoracic echocardiography. Drainage of pericardial effusion was performed to relieve the clinical symptoms. A follow-up echocardiogram showed that the pericardial effusion had decreased; however, the right atrial pressure continued to increase, and signs of constrictive pericarditis were observed upon a more comprehensive inspection. Therefore, the diagnosis of ECP was established based on the comprehensive pre- and post-pericardiocentesis echocardiographic findings. An urgent pericardectomy was subsequently performed, which significantly relieved the patient's clinical symptoms, and the signs of pericardial constriction on echocardiography improved. Pericardial effusion and pericardial culture showed growth of P. aeruginosa.
ECP induced by P. aeruginosa infection remains a rare disease. The presence of echocardiographic features of constrictive pericarditis after pericardiocentesis therapy is highly indicative of ECP.
Core Tip: Effusive-constrictive pericarditis (ECP) is an uncommon clinical syndrome with varied causes, and Pseudomonas aeruginosa (P. aeruginosa) infection is an extremely rare etiology of ECP. This report presents a rare case of P. aeruginosa -induced ECP that was diagnosed based on comprehensive post-pericardiocentesis follow-up echocardiography. The patient was initially misdiagnosed with pure pericardial effusion. This emphasizes the importance of sensitive identification of ECP echocardiographic features and the advantage of follow-up echocardiography after pericardiocentesis for the diagnosis and treatment of ECP.
- Citation: Chen JL, Mei DE, Yu CG, Zhao ZY. Pseudomonas aeruginosa-related effusive-constrictive pericarditis diagnosed with echocardiography: A case report. World J Clin Cases 2022; 10(21): 7577-7584
- URL: https://www.wjgnet.com/2307-8960/full/v10/i21/7577.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i21.7577
Pericardial effusion is a common clinical condition that can be accurately diagnosed using echocardiography. However, when acute pericardial effusion gradually transforms into chronic constrictive pericarditis, which is defined as effusive-constrictive pericarditis (ECP), the diagnosis becomes confusing and may lead to misdiagnosis and inappropriate treatment. As an uncommon clinical syndrome, ECP is characterized by the coexistence of pericardial effusion and constriction of the heart by the visceral pericardium[1]. The persistence of elevated central venous pressure after pericardiocentesis is the hemodynamic characteristic of ECP. The etiologies of ECP include purulent pericarditis, tuberculosis, trauma, and neoplastic involvement[2], of which Pseudomonas aeruginosa (P. aeruginosa) infection represents an extremely small percentage. Follow-up echocardiography is a useful tool for diagnosing and treating ECP. Herein, we report a rare case of ECP caused by P. aeruginosa infection, diagnosed using echocardiography before and after pericardiocentesis.
A 30-year-old man was admitted to our hospital with a 2-mo history of cough, dyspnea, bloating, palpitations, and lower extremity edema (Table 1).
Day 1 | A 30-yr-old man was admitted to our hospital with a 2-mo history of cough, dyspnea, bloating, palpitation, and lower extremity oedema |
Day 2 | The patient was taken to the ultrasound department for an echocardiogram showing a moderate-sized localized pericardial effusion, with an increase in the RAD and LAD (Figure 1) |
Day 5 | The patient underwent pericardiocentesis to relieve the clinical conditions |
Day 6 | The patient's clinical symptoms were slightly relieved |
Day 8 | A repeat echocardiogram showed decreased pericardial effusion compared with the first examination and characteristic manifestations of pericardial constriction. A diagnosis of ECP was established (Figure 2) |
Day 10 | A CT scan demonstrated a small amount of pericardial effusion with thickened pericardium |
Day 15 | PET-CT examination ruled out neoplastic and connective tissue diseases |
Day 17 | The patient underwent pericardectomy, which led to a rapid improvement in the clinical symptoms |
Day 19 | Histologic examination performed on the pericardial tissue obtained during pericardectomy showed increased thickening with the proliferation of collagen fibers, hyaline degeneration, and calcification (Figure 4) |
Day 20 | Cytologic examination of the pericardial fluid obtained during pericardectomy showed many inflammatory cells and few mesothelial cells. Cultures of the pericardial fluid and pericardium grew Pseudomonas aeruginosa |
Day 24 | A repeat 2D-TTE 1 wk after pericardectomy revealed improvement in the biatrial diameter, Doppler features of pericardial constriction, and the right atrial pressure (Figure 3) |
Day 26 | The patient was discharged home in stable condition |
1 mo post-discharge | A follow-up echocardiogram revealed that the right atrial pressure assessed using echocardiography had significantly decreased in the absence of pericardial constriction echocardiographic features (Figure 5) |
He was diagnosed with atrial fibrillation, heart failure, and multiple serous effusions (pleural, pericardial, and abdominal effusions) at a local hospital.
The patient had no history of any previous disease.
The patient had no previous or family history of similar illnesses.
The patient’s vital signs on admission were stable. Cardiac auscultation revealed muffled heart sounds. Palpation revealed mild edema in both the lower extremities. Electrocardiography revealed atrial fibrillation and a decreased voltage.
Blood tests revealed slightly elevated thyroid-stimulating hormone levels, moderately elevated inflammatory markers, and significantly increased N-terminal-pro hormone brain natriuretic peptide levels. The liver and kidney functions were within the normal range. The T-SPOT test yielded a negative result.
Two-dimensional transthoracic echocardiography (2D-TTE), on admission, revealed a significantly enlarged diameter of the left atrium (LAD) and right atrium (RAD) and a moderate pericardial effusion that was predominantly along the apical wall, measuring up to 2 cm (Figure 1). The diagnosis of biatrial enlargement due to atrial fibrillation and localized pericardial effusion was established according to echocardiographic manifestations and history. Emergency surgical pericardial drainage was performed by removing 500 mL purulent fluid to relieve the clinical presentation. Despite the removal of most of the pericardial fluid, which indicates a significant decrease in intrapericardial pressure, the patient's clinical symptoms showed no significant improvement. Subsequent 2D-TTE (Figure 2) failed to show normalization of LAD and RAD. In addition, echocardiography revealed other information with significant diagnostic value, such as abnormal movement of the interventricular septum (“interventricular septum bounce”) and increased pericardial thickness. Notably, pulsed-wave Doppler revealed significant respiratory variation (greater than 25%) in the peak mitral inflow velocity (E) and an increase in the peak velocity blood flow from left ventricular relaxation in early diastole to peak velocity flow in late diastole caused by atrial contraction (E/A) ratio (> 2). Tissue Doppler imaging of the mitral annulus revealed “annulus reversus,” as the lateral mitral e’ velocity was lower than the medial mitral e’ velocity. M-mode echocardiography revealed a dilated inferior vena cava (IVC) with almost no aspiratory variation, according to which the estimated right atrial pressure was elevated (20 mmHg). Thus, a diagnosis of ECP as the underlying cause of the clinical presentation was established according to the pre- and post-pericardiocentesis echocardiographic performance. Computed tomography (CT) scan also revealed a small amount of pericardial effusion with a thickened pericardium. Positron emission tomography-CT (PET-CT) ruled out connective tissue and neoplastic diseases. Clinical and imaging tests revealed the need for urgent surgical removal of the residual pericardial effusion and visceral pericardium. A repeat 2D-TTE 1-wk after pericardectomy revealed that the biatrial diameter and echocardiographic features of pericardial constriction improved, and the right atrial pressure assessed using echocardiography also decreased (Figure 3 and Table 1).
Cytological examination of the pericardial fluid revealed many inflammatory cells and few mesothelial cells. Cultures of the pericardial fluid and the pericardium grew P. aeruginosa. Histological examination of the pericardial tissue obtained during pericardectomy revealed increased thickening with the proliferation of collagen fibers, hyaline degeneration, and calcification (Figure 4 and Table 1).
ECP caused by P. aeruginosa infection.
Emergency surgical pericardial drainage was performed to relieve the clinical presentation by removing 500 mL purulent fluid according to the initial diagnosis of moderate pericardial effusion established by echocardiography. Antibiotics and diuretics were subsequently administered to relieve the symptoms. After the diagnosis of ECP was established via follow-up echocardiography, pericardectomy was performed. During pericardectomy, we observed that the heart was covered by a 2 mm inflammatory membrane, which eventually led to the loss of elasticity of the pericardium, external compression, and diastolic restriction of the heart. Antibiotic therapy was administered to the patient after surgery (Table 1).
It was only after the careful removal of the constricted visceral pericardium that a reduction in the right atrial pressure was observed, and the echocardiographic patterns of constrictive physiology improved. The patient’s clinical symptoms were significantly relieved. Echocardiography performed 1 mo after surgery demonstrated an obvious improvement in the echocardiography data and hemodynamics. It showed that the pericardial effusion was resolved, the RAD and LAD decreased, and the right atrial pressure was also significantly decreased (Figure 5 and Table 1).
ECP is a rare pericardial disease characterized by the coexistence of pericardial constriction and effusion. Its characteristic feature is a persistently elevated right atrial pressure of > 10 mmHg or a reduction of less than 50% from baseline despite pericardiocentesis[3]. The etiology of ECP varies, including idiopathic origin, viral origin, post-procedural origin, radiation, drug-induced, connective tissue disease, malignancy, and tuberculosis. P. aeruginosa is a rare etiological agent of ECP. Given the growth of P. aeruginosa in the pericardial fluid and tissue, this was a case of ECP induced by P. aeruginosa, which is rarely reported in the literature. Infections with P. aeruginosa occur mainly in immunocompromised and neutropenic patients and are associated with the presence of indwelling catheters and disruption of the mucocutaneous barriers. Prior hospitalization and prior use of antibiotics were the most significant risk factors for the acquisition of antibiotic-resistant P. aeruginosa[4]. P. aeruginosa causes a polymorphonuclear reaction that may progress to fibrotic thickening of the pericardium, fibrin deposition and non-specific inflammation, eventually leading to constrictive pericarditis and purulent pericardial effusion[5].
The prevalence of ECP varies from 1.4% to 14% in patients presenting with pericardial effusion[6]. Most pericardial effusions are accurately recognized using echocardiography and do not require drainage with pericardiocentesis; pericardiocentesis is urgently needed to relieve symptoms only in symptomatic patients with cardiac tamponade. For patients with ECP, the clinical condition cannot be improved by drainage of the pericardial effusion alone, and pericardiectomy is a life-saving intervention. Therefore, sensitive identification of pure pericardial effusion and ECP is of vital significance for clinical treatment.
The gold standard for the diagnosis of ECP is invasive hemodynamic evaluation using cardiac catheterization. Echocardiography can provide a potential non-invasive diagnostic tool with high sensitivity and specificity, which shows the coexistence of effusive and constrictive pericardial features[2]. Identification of ECP using echocardiography requires comprehensive observation with 2D, Doppler, and M-mode echocardiography[7]. 2D imaging has an excellent ability to detect effusion, enlarged atrial size, interventricular septum bounce, and a dilated IVC, which are sensitive and specific signs for the initial diagnosis of ECP. The echo-Doppler findings are diagnostically helpful, and it has been proposed that the presence of constrictive pericarditis echocardiographic Doppler features after pericardiocentesis would help clarify the diagnosis of ECP[8,9]. The key characteristic performance features of ECP include “annulus reversus,” restrictive mitral inflow (E/A > 2), greater than 25% respiratory variation in the peak mitral inflow velocity (E)[10]. The M-mode echocardiography can demonstrate a persistently dilated IVC and the posterior motion of the septum during early diastole on inspiration[7,11], providing additional diagnostic information. In the present case, echocardiographic signs of pericardial effusion were observed during the initial examination. However, ECP is relatively rare and cannot be easily diagnosed. As one of the most notable characteristics of pericardial constriction, pericardial thickness was ignored because of a lack of comprehensive understanding of ECP echocardiographic features, leading to a misdiagnosis of localized pericardial effusion. Although pericardial effusion decreased after pericardiocentesis, repeat echocardiography demonstrated that the right atrial pressure evaluated using echocardiography remained high, and the characteristics of pericardial constriction were present, providing sufficient evidence for the appropriate diagnosis of ECP.
The present case of ECP associated with P. aeruginosa infection demonstrated that in patients with localized pericardial effusion who have typical risk factors, such as infection, prior use of antibiotics, and prior hospitalization, the presence of ECP should be highly suspected[3]. Additionally, this case highlighted the significance of sensitive recognition of the echocardiographic features of ECP, including pericardial effusion combined with atrial enlargement, which is the most intuitive feature of constrictive pericarditis. A comprehensive study with 2D imaging, Doppler, and M-mode echocardiography is required to avoid misdiagnosis. More importantly, for patients initially diagnosed with pericardial effusion, the echocardiographic features of constrictive pericarditis after pericardiocentesis should raise a suspicion of ECP[12]. Therefore, when a localized pericardial effusion is detected, follow-up echocardiographic examinations may assist in clinical diagnosis and treatment.
We highlight a rare case of ECP associated with P. aeruginosa infection that was initially misdiagnosed as pericardial effusion using echocardiography. Comprehensive echocardiography, including 2D, M-mode, and Doppler echocardiography, should help avoid misdiagnosis, especially during the follow-up after pericardiocentesis.
Provenance and peer review: Unsolicited article; Externally peer reviewed.
Peer-review model: Single blind
Specialty type: Cardiac and cardiovascular systems
Country/Territory of origin: China
Peer-review report’s scientific quality classification
Grade A (Excellent): 0
Grade B (Very good): B
Grade C (Good): C, C
Grade D (Fair): 0
Grade E (Poor): 0
P-Reviewer: Ghimire R, Nepal; Russo D, Italy A-Editor: Liu X, China S-Editor: Yan JP L-Editor: A P-Editor: Yan JP
1. | Chetrit M, Jain V, Cremer PC, Johnston D, Klein AL. Chronic calcific effusive constrictive pericarditis: a rare entity within the spectrum of pericardial diseases-a case report. Eur Heart J Case Rep. 2020;4:1-3. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis (0)] |
2. | Miranda WR, Oh JK. Effusive-Constrictive Pericarditis. Cardiol Clin. 2017;35:551-558. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis (0)] |
3. | Al-Saiegh Y, Spears J, Barry T, Lee C, Haber H, Goldberg S. Diagnosis and treatment of effusive-constrictive pericarditis: a case report. Eur Heart J Case Rep. 2021;5:ytab174. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
4. | Raman G, Avendano EE, Chan J, Merchant S, Puzniak L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2018;7:79. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 82] [Cited by in F6Publishing: 142] [Article Influence: 20.3] [Reference Citation Analysis (0)] |
5. | El Hassan N, Dbaibo G, Diab K, Musallam S, Haidar R, Obeid M, Bitar F. Pseudomonas pericarditis in an immunocompetent newborn: unusual presentation with review of the literature. J Infect. 2002;44:49-51. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
6. | Paiardi S, Pellegrino M, Cannata F, Bocciolone M, Voza A. Transitory effusive-constrictive pericarditis. Am J Emerg Med. 2018;36:524.e1-524.e6. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
7. | Kalra AG, Sharp AJ, Dinkha L, Gore R. Effusive-Constrictive Pericarditis in a Young Active Duty Male. Cureus. 2020;12:e9997. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
8. | Diaconu R, Popescu L, Voicu A, Donoiu I. Subacute effusive-constrictive pericarditis in a patient with COVID-19. BMJ Case Rep. 2021;14. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis (0)] |
9. | Kim KH, Miranda WR, Sinak LJ, Syed FF, Melduni RM, Espinosa RE, Kane GC, Oh JK. Effusive-Constrictive Pericarditis After Pericardiocentesis: Incidence, Associated Findings, and Natural History. JACC Cardiovasc Imaging. 2018;11:534-541. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis (0)] |
10. | Miranda WR, Newman DB, Oh JK. Effusive-Constrictive Pericarditis: Doppler Findings. Curr Cardiol Rep. 2019;21:144. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
11. | Ohsawa N, Nakaoka Y, Kubokawa SI, Kubo T, Yamasaki N, Kitaoka H, Kawai K, Hamashige N, Doi Y. Subacute effusive-constrictive pericarditis: Echocardiography-guided diagnosis and management. J Cardiol Cases. 2017;16:14-17. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
12. | Giordani AS, De Gaspari M, Baritussio A, Rizzo S, Carturan E, Basso C, Napodano M, Testolin L, Marcolongo R, Caforio ALP. A rare cause of effusive-constrictive pericarditis. ESC Heart Fail. 2021;8:4313-4317. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis (0)] |